Professor Christian Perronne Interview – Part 2
In this second part of our interview with Professor Christian Perronne, MD, PhD, from France, we cover the questions of clinical trials and therapy approval
In this second part of our interview with Professor Christian Perronne, MD, PhD, from France, we cover the questions of clinical trials and therapy approval
Since mid-March, early treatments were known to have great potential as a cure for COVID-19. Dr Zelenko was already treating his patients in NY State
While the hydroxychloroquine arm of the RECOVERY Randomized Clinical Trial was terminated last Friday, the research continues to make waves in the French media, seemingly
There is a video on YouTube showing how to seek consent from volunteer patients to participate in the RECOVERY trial. The video, which serves as
In a video interview today, Professor Didier Raoult, from IHU-Marseille, blasts the Oxford academics having carried out the RECOVERY randomized controlled trials having tested hydroxychloroquine
This June 6th, the France-Soir newspaper published an article titled “Recovery: Brexit & “Overdose”” which points at “very high” fatality rates in the Oxford /
While the first results of the UK RECOVERY trials were expected for July, they were unexpectedly released today June 5. With the epidemic still going
Randomized controlled trials are usually seen as the gold standard when it comes to scientific research. With the COVID-19 crisis, they are now at the
Professor Raoult presents here an epistemological analysis and justifies his scientific methodology concerning the treatment of COVID-19. He considers randomized studies with large cohorts unsuitable
Le Professeur Raoult présente ici une analyse épistémologique et justifie ses méthodes scientifiques concernant le traitement du COVID-19. Il considère les études randomisées avec grandes
The title may seem exaggerated. Yet, it’s based on reality. Canadian research, has opted for self-screening and self-reporting, instead of letting people see a doctor. For
Voici une brève analyse des informations disponibles sur les essais cliniques RECOVERY coordonnés par l’Université d’Oxford et pour lesquels les premiers patients ont déjà été